|
1
|
Nagtegaal ID, Odze RD, Klimstra D, Paradis
V, Rugge M, Schirmacher P, Washington KM, Carneiro F and Cree IA;
WHO Classification of Tumours Editorial Board, : The 2019 WHO
classification of tumours of the digestive system. Histopathology.
76:182–188. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zheng R, Qu C, Zhang S, Zeng H, Sun K, Gu
X, Xia C, Yang Z, Li H, Wei W, et al: Liver cancer incidence and
mortality in China: Temporal trends and projections to 2030. Chin
Jl Cancer Res. 30:571–579. 2018. View Article : Google Scholar
|
|
4
|
Fukata M, Nakagawa M and Kaibuchi K: Roles
of Rho-family GTPases in cell polarisation and directional
migration. Curr Opin Cell Biol. 5:590–597. 2003. View Article : Google Scholar
|
|
5
|
Woodham EF and Machesky LM: Polarised cell
migration: Intrinsic and extrinsic drivers. Chin J Cancer Res.
30:25–32. 2014.
|
|
6
|
Royer C and Lu X: Epithelial cell
polarity: A major gatekeeper against cancer? Cell Death Differ.
18:1470–1477. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jung HY, Fattet L, Tsai JH, Kajimoto T,
Chang Q, Newton AC and Yang J: Apical-basal polarity inhibits
epithelial-mesenchymal transition and tumour metastasis by
PAR-complex-mediated SNAI1 degradation. Nat Cell Biol. 21:359–371.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee M and Vasioukhin V: Cell polarity and
cancer-cell and tissue polarity as a non-canonical tumor
suppressor. J Cell Sci. 121:1141–1150. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Larue L and Bellacosa A:
Epithelial-mesenchymal transition in development and cancer: Role
of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene.
24:7443–7454. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tsai JH and Yang J: Epithelial-mesenchymal
plasticity in carcinoma metastasis. Genes Dev. 27:2192–2206. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Moreno-Bueno G, Portillo F and Cano A:
Transcriptional regulation of cell polarity in EMT and cancer.
Oncogene. 27:6958–6969. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lewin GR and Barde YA: Physiology of the
neurotrophins. Annu Rev Neurosci. 19:289–317. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hetman M and Xia Z: Signaling pathways
mediating anti-apoptotic action of neurotrophins. Acta Neurobiol
Exp (Wars). 60:531–545. 2000.PubMed/NCBI
|
|
15
|
Bradshaw RA, Pundavela J, Biarc J,
Chalkley RJ, Burlingame AL and Hondermarck H: NGF and ProNGF:
Regulation of neuronal and neoplastic responses through receptor
signaling. Adv Biol Regul. 58:16–27. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yoon SO, Casaccia-Bonnefil P, Carter B and
Chao MV: Competitive signaling between TrkA and p75 nerve growth
factor receptors determines cell survival. J Neurosci.
18:3273–3281. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Frade JM, Rodríguez-Tébar A and Barde YA:
Induction of cell death by endogenous nerve growth factor through
its p75 receptor. Nature. 383:166–168. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tokusashi Y, Asai K, Tamakawa S, Yamamoto
M, Yoshie M, Yaginuma Y, Miyokawa N, Aoki T, Kino S, Kasai S, et
al: Expression of NGF in hepatocellular carcinoma cells with its
receptors in non-tumor cell components. Int J Cancer. 114:39–45.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kishibe K, Yamada Y and Ogawa K:
Production of nerve growth factor by mouse hepatocellular carcinoma
cells and expression of TrkA in tumor-associated arteries in mice.
Gastroenterology. 122:1978–1986. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Garrido MP, Torres I, Avila A, Chnaiderman
J, Valenzuela-Valderrama M, Aramburo J, Oróstica L, Durán-Jara E,
Lobos-Gonzalez L and Romero C: NGF/TRKA decrease miR-145-5p levels
in epithelial ovarian cancer cells. Int J Mol Sci. 21:76572020.
View Article : Google Scholar
|
|
21
|
Faulkner S, Griffin N, Rowe CW, Jobling P,
Lombard JM, Oliveira SM, Walker MM and Hondermarck H: Nerve growth
factor and its receptor tyrosine kinase TrkA are overexpressed in
cervical squamous cell carcinoma. FASEB Bioadv. 2:398–408. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Blondy S, Christou N, David V, Verdier M,
Jauberteau MO, Mathonnet M and Perraud A: Neurotrophins and their
involvement in digestive cancers. Cell Death Dis. 10:1232019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu X, Liu Z, Hou R, Nie Y and Chen R:
Nerve growth factor and its receptors on onset and diagnosis of
ovarian cancer. Oncol Lett. 14:2864–2868. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Demir IE, Tieftrunk E, Schorn S, Friess H
and Ceyhan GO: Nerve growth factor & TrkA as novel therapeutic
targets in cancer. Biochim Biophys Acta. 1866:37–50.
2016.PubMed/NCBI
|
|
25
|
Berretta M, Cavaliere C, Alessandrini L,
Stanzione B, Facchini G, Balestreri L, Perin T and Canzonieri V:
Serum and tissue markers in hepatocellular carcinoma and
cholangiocarcinoma: Clinical and prognostic implications.
Oncotarget. 8:14192–14220. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Han P, Fu Y, Liu J, Wang Y, He J, Gong J,
Li M, Tan Q, Li D, Luo Y, et al: Netrin-1 promotes cell migration
and invasion by down-regulation of BVES expression in human
hepatocellular carcinoma. Am J Cancer Res. 5:1396–1409.
2015.PubMed/NCBI
|
|
27
|
Yan W, Han P, Zhou Z, Tu W, Liao J, Li P,
Liu M, Tian D and Fu Y: Netrin-1 induces epithelial-mesenchymal
transition and promotes hepatocellular carcinoma invasiveness. Dig
Dis Sci. 59:1213–1221. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Etienne-Manneville S and Hall A: Cdc42
regulates GSK-3beta and adenomatous polyposis coli to control cell
polarity. Nature. 421:753–756. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang S, Schafer-Hales K, Khuri FR, Zhou
W, Vertino PM and Marcus AI: The tumor suppressor LKB1 regulates
lung cancer cell polarity by mediating cdc42 recruitment and
activity. Cancer Res. 68:740–748. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Frisch SM and Francis H: Disruption of
epithelial cell-matrix interactions induces apoptosis. J Cell Biol.
124:619–626. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yadav S, Puri S and Linstedt AD: A primary
role for golgi positioning in directed secretion, cell polarity,
and wound healing. Mol Biol Cell. 20:1728–1736. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ravichandran Y, Goud B and Manneville JB:
The Golgi apparatus and cell polarity: Roles of the cytoskeleton,
the Golgi matrix, and Golgi membranes. Curr Opin Cell Biol.
62:104–113. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Piroli ME, Blanchette JO and Jabbarzadeh
E: Polarity as a physiological modulator of cell function. Front
Biosci (Landmark Ed). 24:451–462. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Elias BC, Das A, Parekh DV, Mernaugh G,
Adams R, Yang Z, Brakebusch C, Pozzi A, Marciano DK, Carroll TJ and
Zent R: Cdc42 regulates epithelial cell polarity and cytoskeletal
function during kidney tubule development. J Cell Sci.
128:4293–4305. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Melck D, De Petrocellis L, Orlando P,
Bisogno T, Laezza C, Bifulco M and Di Marzo V: Suppression of nerve
growth factor Trk receptors and prolactin receptors by
endocannabinoids leads to inhibition of human breast and prostate
cancer cell proliferation. Endocrinology. 141:118–126. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gandalovičová A, Vomastek T, Rosel D and
Brábek J: Cell polarity signaling in the plasticity of cancer cell
invasiveness. Oncotarget. 7:25022–25049. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fuertes-Alvarez S, Maeso-Alonso L,
Villoch-Fernandez J, Wildung M, Martin-Lopez M, Marshall C,
Villena-Cortes AJ, Diez-Prieto I, Pietenpol JA, Tissir F, et al:
p73 regulates ependymal planar cell polarity by modulating actin
and microtubule cytoskeleton. Cell Death Dis. 9:11832018.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lomakin AJ, Lee KC, Han SJ, Bui DA,
Davidson M, Mogilner A and Danuser G: Competition for actin between
two distinct F-actin networks defines a bistable switch for cell
polarization. Nat Cell Biol. 17:1435–445. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Olson MF and Sahai E: The actin
cytoskeleton in cancer cell motility. Clin Exp Metastasis.
26:273–287. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Witsch E, Sela M and Yarden Y: Roles for
growth factors in cancer progression. Physiology (Bethesda).
25:85–101. 2010.PubMed/NCBI
|
|
41
|
Okamoto M, Koma YI, Kodama T, Nishio M,
Shigeoka M and Yokozaki H: Growth differentiation factor 15
promotes progression of esophageal squamous cell carcinoma via
TGF-β type II receptor activation. Pathobiology. 87:100–113. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
West NR, McCuaig S, Franchini F and Powrie
F: Emerging cytokine networks in colorectal cancer. Nat Rev
Immunol. 15:615–629. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhou X, Hao Q, Liao P, Luo S, Zhang M, Hu
G, Liu H, Zhang Y, Cao B, Baddoo M, et al: Nerve growth factor
receptor negates the tumor suppressor p53 as a feedback regulator.
Elife. 5:e150992016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Luo T, Zhang SG, Zhu LF, Zhang F, Li W,
Zhao K, Wen XX, Yu M, Zhan YQ, Chen H, et al: A selective c-Met and
Trks inhibitor Indo5 suppresses hepatocellular carcinoma growth. J
Exp Clin Cancer Res. 38:1302019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lagadec C, Meignan S, Adriaenssens E,
Foveau B, Vanhecke E, Romon R, Toillon RA, Oxombre B, Hondermarck H
and Le Bourhis X: TrkA overexpression enhances growth and
metastasis of breast cancer cells. Oncogene. 28:1960–1970. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Festuccia C, Muzi P, Gravina GL,
Millimaggi D, Speca S, Dolo V, Ricevuto E, Vicentini C and Bologna
M: Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor
and limits the invasive capability of prostate cancer cells in
vitro. Int J Oncol. 30:193–200. 2007.PubMed/NCBI
|
|
47
|
Tsai MS, Lee PH, Sun CK, Chiu TC, Lin YC,
Chang IW, Chen PH and Kao YH: Nerve growth factor upregulates
sirtuin 1 expression in cholestasis: A potential therapeutic
target. Exp Mol Med. 50:e4262018. View Article : Google Scholar : PubMed/NCBI
|
